These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

680 related items for PubMed ID: 10366457

  • 1. Outcome of pregnancies occurring before completion of human chorionic gonadotropin follow-up in patients with persistent gestational trophoblastic tumor.
    Tuncer ZS, Bernstein MR, Goldstein DP, Berkowitz RS.
    Gynecol Oncol; 1999 Jun; 73(3):345-7. PubMed ID: 10366457
    [Abstract] [Full Text] [Related]

  • 2. Persistent trophoblast disease following partial molar pregnancy.
    Wielsma S, Kerkmeijer L, Bekkers R, Pyman J, Tan J, Quinn M.
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):119-23. PubMed ID: 16638033
    [Abstract] [Full Text] [Related]

  • 3. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG, Wielsma S, Massuger LF, Sweep FC, Thomas CM.
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [Abstract] [Full Text] [Related]

  • 4. [Value of the radioimmunological assay of HCG and its subunits in the diagnosis and follow-up of gestational trophoblastic disease].
    Delpont PJ, Ruf H, Blanc B, Gamerre M, Adrai J, Conte M, Dupont S, Bellia-Rousseau J.
    Rev Fr Gynecol Obstet; 1985 Oct; 80(10):737-52. PubMed ID: 2417299
    [Abstract] [Full Text] [Related]

  • 5. Duration of human chorionic gonadotropin surveillance for partial hydatidiform moles.
    Lavie I, Rao GG, Castrillon DH, Miller DS, Schorge JO.
    Am J Obstet Gynecol; 2005 May; 192(5):1362-4. PubMed ID: 15902109
    [Abstract] [Full Text] [Related]

  • 6. Persistent low-level "real" human chorionic gonadotropin: a clinical challenge and a therapeutic dilemma.
    Kohorn EI.
    Gynecol Oncol; 2002 May; 85(2):315-20. PubMed ID: 11972394
    [Abstract] [Full Text] [Related]

  • 7. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA, Khanlian SA, Giddings A, Butler SA, Muller CY, Hammond C, Kohorn E.
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [Abstract] [Full Text] [Related]

  • 8. [Clinical significance of pregnancy-specific beta glycoprotein, human placental lactogen and beta-human chorionic gonadotropin in the serum of patients with trophoblastic diseases].
    Zhang WY.
    Zhonghua Yi Xue Za Zhi; 1989 Apr; 69(4):206-8, 16. PubMed ID: 2476204
    [Abstract] [Full Text] [Related]

  • 9. Early detection of persistent trophoblastic tumour by serum human chorionic gonadotrophin monitoring after molar pregnancy.
    Ngan HY, Wong LC.
    Chin Med J (Engl); 1999 Mar; 112(3):260-3. PubMed ID: 11593563
    [Abstract] [Full Text] [Related]

  • 10. Metastatic gestational trophoblastic disease: prognostic factors in previously untreated patients.
    Soper JT, Clarke-Pearson D, Hammond CB.
    Obstet Gynecol; 1988 Mar; 71(3 Pt 1):338-43. PubMed ID: 2831487
    [Abstract] [Full Text] [Related]

  • 11. Gestational trophoblastic disease. Subsequent pregnancy outcome, including repeat molar pregnancy.
    Berkowitz RS, Im SS, Bernstein MR, Goldstein DP.
    J Reprod Med; 1998 Jan; 43(1):81-6. PubMed ID: 9475154
    [Abstract] [Full Text] [Related]

  • 12. Measurement of CA-125 in trophoblastic disease.
    Kohorn EI.
    Gynecol Oncol; 2000 Jul; 78(1):39-42. PubMed ID: 10873407
    [Abstract] [Full Text] [Related]

  • 13. Pregnancy outcome of patients conceiving within one year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 cases.
    Zhu L, Song H, Yang X, Xiang Y.
    Chin Med J (Engl); 1998 Nov; 111(11):1004-6. PubMed ID: 11189204
    [Abstract] [Full Text] [Related]

  • 14. Low risk of relapse after achieving undetectable HCG levels in women with complete molar pregnancy.
    Wolfberg AJ, Feltmate C, Goldstein DP, Berkowitz RS, Lieberman E.
    Obstet Gynecol; 2004 Sep; 104(3):551-4. PubMed ID: 15339768
    [Abstract] [Full Text] [Related]

  • 15. [Combination chemotherapy with etoposide and cisplatin for high-risk, chemorefractory and recurrent gestational trophoblastic neoplasia].
    Jiang J, Nan FF, Yang XS, Zhang YZ, Wang B, Kong BH.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):595-9. PubMed ID: 17983513
    [Abstract] [Full Text] [Related]

  • 16. Serum granulocyte macrophage colony stimulating factor (GM-CSF) in gestational trophoblastic diseases.
    Shaarawy M, el-Shobokshy AS, el-Noury AI.
    Cytokine; 1995 Feb; 7(2):171-5. PubMed ID: 7540057
    [Abstract] [Full Text] [Related]

  • 17. Pregnancy outcomes of patients who conceived within 1 year after chemotherapy for gestational trophoblastic tumor: a clinical report of 22 patients.
    Lan Z, Hongzhao S, Xiuyu Y, Yang X.
    Gynecol Oncol; 2001 Oct; 83(1):146-8. PubMed ID: 11585428
    [Abstract] [Full Text] [Related]

  • 18. Twenty-five years' clinical experience with placental site trophoblastic tumors.
    Papadopoulos AJ, Foskett M, Seckl MJ, McNeish I, Paradinas FJ, Rees H, Newlands ES.
    J Reprod Med; 2002 Jun; 47(6):460-4. PubMed ID: 12092014
    [Abstract] [Full Text] [Related]

  • 19. Gestational trophoblastic disease: treatment results at the Brewer Trophoblastic Disease Center.
    Lurain JR, Brewer JI, Torok EE, Halpern B.
    Obstet Gynecol; 1982 Sep; 60(3):354-60. PubMed ID: 6289207
    [Abstract] [Full Text] [Related]

  • 20. Clinical features of multiple conception with partial or complete molar pregnancy and coexisting fetuses.
    Steller MA, Genest DR, Bernstein MR, Lage JM, Goldstein DP, Berkowitz RS.
    J Reprod Med; 1994 Mar; 39(3):147-54. PubMed ID: 8035369
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.